Farmakon SRL
Farmakon reported total assets of 736,423 € at the end of the 2025 financial year (annual accounts filed with the NBB on 18 Aug 2026).
The score of Farmakon shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +15 % Total assets +17 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Farmakon's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 18 Aug 2026
- Year ended 31 Dec 2024filed on 28 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 29 Aug 2023
- Year ended 31 Dec 2021filed on 26 Aug 2022
Farmakon's financial analysis
- Solvency92.5%sector median: 55.6%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Farmakon
Farmakon's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0465.507.453
- VAT number
- BE0465507453
- Peppol
- Registered · 0208:0465507453 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 23 Feb 1999
- Registered office
- 9255 Buggenhout
- Latest accounts
- 2025 · filed on 18 Aug 2026
- Activity
- Activities of holding companies (NACE 64210)
Farmakon (SRL) has been based in Buggenhout since 1999, active in: activities of holding companies. For 2025, it reports a net profit of 55,869 € and equity of 680,844 €; its revenue is not published. Its solvency stands at 92.5%, above the median of its sector (55.6%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Farmakon
Companies in the same business, of comparable size and area, outside its group.
- VNZ Activities of holding companies Zonhoven · balance sheet 736,250 €
- EBM-Projects Activities of holding companies Hechtel-Eksel · balance sheet 736,164 €
- Le Bourg Activities of holding companies Ghent · balance sheet 735,871 €
- ONNEA Venture Capital Activities of holding companies Deinze · balance sheet 737,004 €
- Beyond Activities of holding companies Bonheiden · balance sheet 737,334 €
- Belglo Activities of holding companies Wijnegem · balance sheet 738,406 €
- Darbi Activities of holding companies Laakdal · balance sheet 734,135 €
- Armatop Activities of holding companies Bruges · balance sheet 738,774 €
Frequently asked questions about Farmakon
What is the revenue of Farmakon?
Farmakon files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Farmakon?
In Belgium, the VAT number is the company number prefixed with BE: BE0465507453 for Farmakon, if the company is VAT-registered. Its company number (CBE) is 0465.507.453.
Where is the registered office of Farmakon?
According to the CBE register, the registered office of Farmakon is in 9255 Buggenhout.
What is the equity of Farmakon?
At the close of the 2025 financial year, the equity of Farmakon amounts to 680,844 €, a solvency of 92.5% of total assets.
Who manages Farmakon?
The register lists 1 active mandates at Farmakon. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Farmakon
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →